AI Beat

HealthDaily digest, October 17, 2026

AI Safety and Genomic Frontiers in Healthcare

This week in AI healthcare, we see progress in ensuring AI-powered medical devices are safe and trustworthy, while scientists reveal important limitations in using AI to understand human genetics. These developments highlight both the promise and current boundaries of artificial intelligence in medicine.

London Certifier Scarlet Raises $50M to Expand AI Medical Device Safety

Scarlet, a company that verifies AI and software used in medical devices, secured $50 million in Series B funding to grow its operations in the US and Asia-Pacific regions. As AI becomes more common in medical devices, independent certification ensures these tools are safe and meet regulatory standards before healthcare providers use them.

Why it matters: As medical devices increasingly incorporate AI, third-party certification helps ensure safety and regulatory compliance, which is essential for patients and healthcare providers adopting these technologies.

Sources: via Techmeme

AI Still Cannot Decode the Full Complexity of Human Genetics

Current AI models lack enough data to fully understand how human genomes actually work, which is far more complicated than simply reading genetic instructions. This limitation means AI cannot yet solve major genetic research problems at scale, slowing progress in personalized medicine and genetic treatments.

Why it matters: This highlights limitations in applying AI to personalized medicine and genetic research, showing that current AI approaches cannot yet solve complex biological problems at scale.

Sources: Wired